Radiation oncology is the medical specialty focused on treating cancer with precisely targeted radiation. It is one of three core branches of cancer treatment, alongside surgical oncology and medical oncology (which covers chemotherapy and related drug therapies). Roughly 50% of all cancer patients receive radiation therapy at some point during their illness, and it contributes to about 40% of all cancer cures.
How Radiation Kills Cancer Cells
Radiation works by damaging the DNA inside cancer cells. High-energy beams break the DNA strands directly, and they also generate unstable oxygen molecules inside cells that cause additional damage to DNA and other cellular structures. When a cell’s DNA is damaged beyond repair, the cell triggers its own death, a built-in safety mechanism that prevents damaged cells from dividing further.
Cancer cells are generally more vulnerable to this kind of damage than healthy cells because they divide rapidly and have weaker DNA repair systems. Healthy tissue can usually recover between treatment sessions, which is why radiation is typically delivered in small daily doses over several weeks rather than all at once. This approach, called fractionation, gives normal tissue time to heal while steadily accumulating lethal damage in the tumor.
Curative vs. Palliative Radiation
Radiation serves two broad purposes. Curative (sometimes called “radical”) radiation aims to eliminate the cancer entirely. Head and neck cancers, cervical cancers, prostate cancers, and many lung cancers are commonly treated with curative-intent radiation, sometimes combined with chemotherapy or surgery.
Palliative radiation, by contrast, is used to relieve symptoms rather than cure the disease. A common example is treating painful bone metastases in advanced cancer. The goal is comfort and quality of life: shrinking a tumor enough to reduce pain, stop bleeding, or relieve pressure on a nerve or organ. Palliative courses tend to be shorter, often just a few sessions.
Types of External Beam Radiation
Most radiation therapy is delivered from a machine outside the body. Several techniques exist, each suited to different clinical situations.
- Intensity-modulated radiation therapy (IMRT): Uses many small beams aimed from multiple angles, with the strength of each beam adjusted so higher doses hit the tumor and lower doses reach surrounding tissue. This is the workhorse technique for many cancers.
- Image-guided radiation therapy (IGRT): A refinement of IMRT that uses repeated imaging scans during treatment to detect changes in tumor size or position. Your treatment can be adjusted in real time if the tumor has shifted even slightly.
- Stereotactic body radiation therapy (SBRT): Delivers very high, precisely focused doses to small tumors, typically in the lung or liver. It is often completed in just three to five sessions and can be an alternative for patients who cannot undergo surgery.
- Proton therapy: Uses charged particles instead of standard X-ray beams. Protons stop once they reach the tumor rather than passing through the body, which can reduce radiation exposure to surrounding healthy tissue. The machines are large and expensive, so proton therapy is available at fewer centers.
Internal Radiation: Brachytherapy
Instead of aiming a beam from outside, brachytherapy places a radiation source directly inside or next to the tumor. Small seeds, ribbons, or capsules containing radioactive material are positioned through a catheter or applicator. This approach delivers a concentrated dose to the tumor while sparing more distant tissue.
There are several forms. Low-dose-rate implants stay in place for one to seven days. High-dose-rate implants are inserted for just 10 to 20 minutes at a time, repeated over several sessions. Permanent implants, often used in prostate cancer, remain in the body indefinitely but lose their radioactivity over weeks to months. A specialized technique called radioembolization delivers tiny radioactive beads into the blood vessel feeding a liver tumor.
What the Treatment Process Looks Like
Before any radiation is delivered, you go through a planning stage called simulation. You lie on a treatment table while the team takes a CT scan of the area to be treated. They may also use MRI or PET scans. Small permanent tattoos (tiny dots) are placed on your skin so therapists can position you in exactly the same way for every session. Depending on the treatment site, you may be fitted with a custom mold, mask, or other device to keep you still.
After simulation, the dosimetry team uses specialized software to design your treatment plan. They map out the tumor and nearby healthy organs, then calculate beam angles and doses that maximize radiation to the cancer while minimizing exposure to everything else. This planning process can take a week or more. Once the radiation oncologist approves the plan, physicists verify it on the actual treatment machine before your first session.
Daily treatments are typically quick. You lie in the same position as during simulation, therapists align your tattoos with lasers in the room, and imaging confirms you are positioned correctly. The radiation itself is painless and usually takes only a few minutes. A standard curative course runs five days a week for several weeks, though SBRT and palliative treatments are much shorter.
Common Side Effects
Side effects depend heavily on which part of the body is being treated. They fall into two categories: acute effects that appear during or shortly after treatment, and late effects that can emerge months to years later.
Acute Effects
Skin redness and irritation in the treatment area are the most universal early side effects, similar to a sunburn. Radiation to the head and neck often causes mouth sores, dry mouth, taste changes, and difficulty swallowing. Chest radiation can trigger a cough, shortness of breath, or chest discomfort from inflammation of the lung tissue. Radiation to the abdomen or pelvis commonly causes nausea, cramping, and diarrhea, typically starting two to three weeks into treatment. Fatigue is nearly universal regardless of the treatment site.
Late Effects
Late side effects are less common but can be more lasting. Radiation to the head and neck can cause permanent dry mouth, jaw stiffness (affecting 5 to 10% of patients), and long-term swallowing difficulty. Chest radiation, particularly for breast cancer, raises the risk of heart problems that may not appear for a decade or more, including inflammation of the heart lining and narrowing of the coronary arteries. Lung fibrosis, where healthy lung tissue is replaced by scar tissue, can develop gradually over months to years. In rare cases, radiation to the brain or spinal cord can cause lasting neurological changes including cognitive effects or nerve damage.
The Radiation Oncology Team
A number of specialized professionals are involved in your care beyond the radiation oncologist who prescribes and oversees your treatment. Medical physicists hold doctoral or master’s degrees and are responsible for ensuring treatment machines work correctly, verifying treatment plans, and performing regular safety checks on equipment. Dosimetrists use planning software to design the exact beam arrangements and dose distributions for each patient, working closely with the physicist and radiation oncologist. Radiation therapists are the professionals you see most often. They position you on the table each day, operate the treatment machine, and monitor you throughout each session.
This team-based structure means that by the time radiation reaches you, your plan has been designed, reviewed, and verified by multiple specialists. Quality assurance checks are built into every stage of the process, from simulation through daily delivery.
AI in Treatment Planning
Artificial intelligence is increasingly being used in radiation oncology, particularly in the treatment planning stage. AI tools can automatically outline tumors and healthy organs on imaging scans, a task called contouring that traditionally takes considerable time when done by hand. AI-based planning software can also generate optimized treatment plans more quickly, potentially improving consistency and freeing the clinical team to focus on complex decision-making. These tools are being evaluated in clinical trials and are gradually entering routine practice at major cancer centers.